Preliminary research suggest conolidine may inhibit distinct ion channels, cutting down neuronal excitability and limiting suffering signals. This mechanism is particularly pertinent in neuropathic discomfort, where by irregular signaling results in persistent pain. On top of that, conolidine seems to impact G protein-coupled receptor (GPCR) pathwa